SCHEMBL15925271

SCHEMBL15925271

CN1CCN(c2cnc3c(CCc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)c(F)c4)ccnc3n2)CC1

nearest known ligand 0.71

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BRAF P15056 15/20 0.71
RAF1 P04049 1/20 0.41
MET P08581 4/20 0.41
KDR P35968 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15925272 0.83 BRAF (0.69) BRAFRAF1KDR
SCHEMBL3757066 0.83 BRAF (1.00) BRAF
SCHEMBL3763280 0.74 BRAF (1.00) BRAFKDR
SCHEMBL29844360 0.71 MAPK14 (0.67) BRAFKDR
SCHEMBL23201782 0.71 MAPK14 (0.67) BRAFKDR
SCHEMBL15925246 0.68 BRAF (0.54) BRAF
SCHEMBL15925266 0.67 BRAF (0.70) BRAF
SCHEMBL15925268 0.67 BRAF (0.51) BRAFRAF1KDR
SCHEMBL3759453 0.66 BRAF (0.72) BRAFKDR
SCHEMBL3759436 0.66 BRAF (1.00) BRAFKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2229391-B1 PYRIDO[2,3-B]PYRAZINE-8-SUBSTITUTED COMPOUNDS AND THEIR USE CANCER REC TECH LTD (GB) 2014-08-06 EP disclosed